BioSpace News Archive

Lohman Technologies, a leader in home ECG monitoring solutions, released the findings from a 90-day pilot study at a Memphis, TN clinic.

A COVID-19 investigational vaccine, developed by City of Hope scientists and now licensed to GeoVax Labs Inc., produced a robust neutralizing antibody and T cell response against SARS-CoV-2 with no significant side effects in a Phase 1 clinical trial led by John Zaia, M.D., Aaron D. Miller and Edith Miller Chair for Gene Therapy, according to a study published in The Lancet Microbe.

The global chemiluminescence immunoassay market size is predicted to reach valuation of around US$ 10.6 billion by 2027 and poised to grow at a CAGR of around 7.6% from 2022 to 2027.

Sunshine Biopharma, Inc. announced that it entered into a securities purchase agreement with certain institutional and accredited investors for aggregate gross proceeds of approximately $8.0 million, before deducting fees to the placement agent and other offering expenses payable by the Company.

The global dental services market size is expanding over US$ 698.8 billion by 2030 from at US$ 371.4 billion in 2020, poised to grow at a CAGR of 6.4% from 2021 to 2030.

The industry analysis report is considered a valuable source of information about the global 3D Printing in Healthcare industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

DepYmed, Inc. (“DepYmed” or the “Company”) and the Monash Biomedicine Discovery Institute (“Monash BDI”) at Monash University in Melbourne, Australia announce today that they have entered into a sponsored research agreement (SRA) to explore the potential of the Company’s drug development candidates to treat cancer by targeting a newly discovered intracellular immune checkpoint.

The industry analysis report is considered a valuable source of information about the global Valley Fever industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

The global healthcare additive manufacturing market size is projected to surpass around US$ 9.87 billion by 2030 from valued at US$ 1.65 billion in 2021, growing at a CAGR of 22% from 2021 to 2030.

MorphoSys AG announces that it will account for a non-cash impairment charge on goodwill in the amount of approximately € 231 million.